Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Huayu for COVID-19 Pneumonia
NCT04645407Phase 4Completed
- Sponsor
- Shuguang Hospital
- Start
- Feb 2020
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fuzheng huayu in coronavirus disease 2019 (COVID-19), sponsored by Shuguang Hospital. Started Feb 2020; status: completed.
02
Drugs
fuzheng huayu
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04645407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04645407.